Skip to content

Evaluation of the Effectiveness of Prepectoral Breast Reconstruction

Evaluation of the Effectiveness of the Prepectoral Breast Reconstruction With Braxon Dermal Matrix: a Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05125991
Enrollment
58
Registered
2021-11-18
Start date
2019-09-03
Completion date
2024-12-31
Last updated
2023-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The study plans to compare conventional submuscular reconstruction with definitive implant and muscle sparing reconstruction with definitive implant in selected patients. The two techniques are compared in terms of patient quality of life and satisfaction; patient related outcomes, reconstruction morbidity, early and late complications are also investigated.

Detailed description

The study plans to compare conventional submuscular reconstruction with definitive implant and muscle sparing reconstruction with definitive implant in selected patients. The two techniques are compared in terms of patient quality of life and satisfaction; patient related outcomes, reconstruction morbidity, early and late complications are also investigated. The study plans to collect robust data to support the prepectoral implant placement and complete coverage of implant with acellular dermal matrix in the clinical practice. Consequently, the project plans to move toward evidence-based medicine in breast reconstruction, avoiding marketing influences and surgeon experience as the sole source of evidence.

Interventions

Prepectoral breast reconstruction

PROCEDURESubmuscolar reconstruction

Submuscolar breast reconstruction

Sponsors

European Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Informed consent 2. Not smokers 3. No vascular comorbidities (diabetic, vasculitis, coagulation disorders) 4. BMI\<30 5. CUP B-C (or mastectomy estimated weight less than 550gm) 6. Good subcutaneous layer (\>1cm on pinch test measured in upper/medial quadrant) 7. No previous breast surgery 8. No previous breast irradiation 9. Breast Ptosis 1-2 according to Renault's classification 10. DCIS tumors 11. T1 T2 pN0 breast tumor with known favourable biologic features

Exclusion criteria

1. Impossibility of immediate reconstruction with definitive implants due to inadequacy of mastectomy flaps (inadequate in quantity and/or quality) 2. Positive sentinel node biopsy requiring complete axillary dissection

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction assessed by the BREAST-Q1 yearThe BREAST-Q survey is used to detect differences in patient satisfaction among the groups

Secondary

MeasureTime frameDescription
Immediate complications rate1 monthCompare post operative complications
Short term complications rate6 monthsCompare short term post operative complications
Long term complications rate24 monthsCompare long term post operative complications
Percentage of capsular contracture1 yearCompare overall aesthetic outcomes (percentage of capsular contracture) using standardized photographs assessed by independent blinded observers

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026